AIIMS Jammu has achieved a major milestone in cancer care by successfully performing<a href="https://www.mid-day.com/lifestyle/culture/article/jammu-and-kashmir-cm-omar-abdullah-extends-greetings-to-devotees-on-kheer-bhawani-mela-23636260" rel="nofollow"> Jammu and Kashmir's</a> first-ever interstitial brachytherapy procedure on a 26-year-old woman diagnosed with Stage II vulvar cancer, the institute said.
Vulvar cancer is a rare gynaecological malignancy, accounting for only four percent of all gynaecological cancers, and is particularly uncommon in young patients.
The case was extensively reviewed by a multidisciplinary tumour board comprising experts from the Departments of Obstetrics and Gynaecology, Radiation Oncology, Surgical Oncology, Radiodiagnosis, and Pathology to formulate an individualized treatment strategy, the AIIMS Jammu said in a statement.
It said the interstitial brachytherapy procedure was successfully performed by the Department of Radiation Oncology under the leadership of Prof (Dr) D N Sharma, Executive Director &amp; CEO, AIIMS Jammu.
This highly specialized technique allows precise delivery of radiation directly into the tumour, maximizing treatment effectiveness while minimizing exposure to surrounding healthy tissues, the institute said.
It said a significant advantage of this approach is that it enabled the patient to avoid a <a href="https://www.mid-day.com/news/india-news/article/mumbai-doctors-remove-sickle-from-mans-head-after-rare-surgery-23628829" rel="nofollow">mutilating surgical procedure</a>, which is particularly important in young women.
This organ-preserving treatment offers the potential for excellent disease control while maintaining the patient's quality of life.
Prof Sharma highlighted that this landmark procedure marks a significant step towards introducing advanced, organ-preserving cancer treatment modalities in the region.
This achievement reinforces AIIMS Jammu's commitment to delivering state-of-the-art oncology services and ensuring that <a href="https://www.mid-day.com/lifestyle/health-and-fitness/article/over-32000-cancer-cases-reported-in-recent-years-in-jammu-and-kashmir-23616462" rel="nofollow">patients in Jammu &amp; Kashmir</a> have access to the latest cancer treatment options within the Union Territory itself, the statement said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

AIIMS Jammu has achieved a major milestone in cancer care by successfully performing Jammu and Kashmir`s first-ever interstitial brachytherapy procedure

AIIMS Jammu makes history with Jammu and Kashmir's first vulvar cancer brachytherapy

The slow-cook philosophy: Why you should ditch salads during the monsoon

It said the interstitial brachytherapy procedure was successfully performed by the Department of Radiation Oncology under the leadership of Prof (Dr) D N Sharma, Executive Director & CEO, AIIMS Jammu


AIIMS Jammu performs Jammu and Kashmir's first vulvar cancer brachytherapy

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / Lifestyle / Health & Fitness / Article / AIIMS Jammu performs Jammu and Kashmir's first vulvar cancer brachytherapy